Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chor-Sang Chim

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Biochimica Et Biophysica Acta|May 31, 2014
RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironmentLingqing Yuan, Godfrey Chi Fung Chan, Kwong Lam Fung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Multiple myeloma presenting as interstitial lung diseaseAda Tin Wei Ma, Regina Cheuk Lam Lo, Yue Cheng, et al.
Blood|March 20, 2004
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patientsWing-Yan Au, Annie Pang, Carolyn Choy, et al.
Frontiers in Oncology|February 15, 2021
Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCRQiumei Yao, Yinlei Bai, Shaji Kumar, et al.
AJR. American Journal of Roentgenology|February 25, 2006
Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomasGaik Cheng Ooi, James Chor-Sang Chim, Wing-Yeh Au, et al.
Frontiers in Genetics|November 20, 2012
DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's LymphomasRita Lok-Hay Yim, Yok Lam Kwong, Kwan Yeung Wong, et al.
Therapeutic Advances in Hematology|October 7, 2021
Case series: MRD negativity assessment using <sup>11</sup>C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myelomaCheong Ngai, Shaji Kumar, Garrett Chi-Lai Ho, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2021
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myelomaChor Sang Chim, Shaji Kumar, Vincent Kai Chung Wong, et al.
Blood|February 21, 2004
SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathwayChor-Sang Chim, Tsz-Kin Fung, Wai-Chung Cheung, et al.
Journal of Clinical Pathology|April 10, 2015
Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myelomaQi Zhang, Lu Qian Wang, Kwan Yeung Wong, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Biochimica Et Biophysica Acta|May 31, 2014
RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironmentLingqing Yuan, Godfrey Chi Fung Chan, Kwong Lam Fung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2010
Multiple myeloma presenting as interstitial lung diseaseAda Tin Wei Ma, Regina Cheuk Lam Lo, Yue Cheng, et al.
Blood|March 20, 2004
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patientsWing-Yan Au, Annie Pang, Carolyn Choy, et al.
Frontiers in Oncology|February 15, 2021
Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma: A Comparison With Real-Time Quantitative PCRQiumei Yao, Yinlei Bai, Shaji Kumar, et al.
AJR. American Journal of Roentgenology|February 25, 2006
Radiologic manifestations of primary solitary extramedullary and multiple solitary plasmacytomasGaik Cheng Ooi, James Chor-Sang Chim, Wing-Yeh Au, et al.
Frontiers in Genetics|November 20, 2012
DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's LymphomasRita Lok-Hay Yim, Yok Lam Kwong, Kwan Yeung Wong, et al.
Therapeutic Advances in Hematology|October 7, 2021
Case series: MRD negativity assessment using <sup>11</sup>C-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myelomaCheong Ngai, Shaji Kumar, Garrett Chi-Lai Ho, et al.
Hematology (Amsterdam, Netherlands)|September 3, 2021
3-weekly daratumumab-lenalidomide/pomalidomide-dexamethasone is highly effective in relapsed and refractory multiple myelomaChor Sang Chim, Shaji Kumar, Vincent Kai Chung Wong, et al.
Blood|February 21, 2004
SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathwayChor-Sang Chim, Tsz-Kin Fung, Wai-Chung Cheung, et al.
Journal of Clinical Pathology|April 10, 2015
Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myelomaQi Zhang, Lu Qian Wang, Kwan Yeung Wong, et al.
Pageof 10